Differences in the tumor transcriptomic profile of patients (pts) with advanced prostate cancer (PCa) with and without diabetes mellitus (DM).

Authors

null

Nishita Tripathi

Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

Nishita Tripathi , Haoran Li , Beverly Chigarira , Shruti Adidam Kumar , Kim JongTaek , Nicolas Sayegh , Georges Gebrael , Yeonjung Jo , Kamal Kant Kant Sahu , Vinay Mathew Thomas , Roberto Nussenzveig , Divyam Goel , Clara Tandar , Nityam Rathi , Umang Swami , Neeraj Agarwal , Benjamin L. Maughan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 244)

DOI

10.1200/JCO.2023.41.6_suppl.244

Abstract #

244

Poster Bd #

J7

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.

Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.

First Author: William Gesztes

First Author: Alin Chirindel